Entrada Therapeutics Retained Earnings (Accumulated Deficit) 2020-2024 | TRDA
Entrada Therapeutics retained earnings (accumulated deficit) from 2020 to 2024. Retained earnings (accumulated deficit) can be defined as profits reinvested in the corporation after dividends have been paid out.